Catalyst Wire Dossier Catalyst Wire Dossier

SLC022

· Solace Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SLC022, covering 2009-07-30 to 2009-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia [Phase 2]

See pricing